Does USTEKINUMAB Cause Therapy interrupted? 164 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 164 reports of Therapy interrupted have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.2% of all adverse event reports for USTEKINUMAB.
164
Reports of Therapy interrupted with USTEKINUMAB
0.2%
of all USTEKINUMAB reports
1
Deaths
58
Hospitalizations
How Dangerous Is Therapy interrupted From USTEKINUMAB?
Of the 164 reports, 1 (0.6%) resulted in death, 58 (35.4%) required hospitalization, and 2 (1.2%) were considered life-threatening.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 164 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which USTEKINUMAB Alternatives Have Lower Therapy interrupted Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE